Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 518 entries
Sorted by: Best Match Show Resources per page
Antidepressant activity of fingolimod in mice.

Pharmacology research & perspectives

di Nuzzo L, Orlando R, Tognoli C, Di Pietro P, Bertini G, Miele J, Bucci D, Motolese M, Scaccianoce S, Caruso A, Mauro G, De Lucia C, Battaglia G, Bruno V, Fabene PF, Nicoletti F.
PMID: 26171219
Pharmacol Res Perspect. 2015 Jun;3(3):e00135. doi: 10.1002/prp2.135. Epub 2015 May 24.

Recent findings indicate that fingolimod, the first oral drug approved for the treatment of multiple sclerosis (MS), acts as a direct inhibitor of histone deacetylases (HDACs) and enhances the production of brain-derived neurotrophic factor (BDNF) in the CNS. Both...

Cite
di Nuzzo L, Orlando R, Tognoli C, et al. Antidepressant activity of fingolimod in mice. Pharmacol Res Perspect. 2015;3(3):e00135doi: 10.1002/prp2.135.
di Nuzzo, L., Orlando, R., Tognoli, C., Di Pietro, P., Bertini, G., Miele, J., Bucci, D., Motolese, M., Scaccianoce, S., Caruso, A., Mauro, G., De Lucia, C., Battaglia, G., Bruno, V., Fabene, P. F., & Nicoletti, F. (2015). Antidepressant activity of fingolimod in mice. Pharmacology research & perspectives, 3(3), e00135. https://doi.org/10.1002/prp2.135
di Nuzzo, Luigi, et al. "Antidepressant activity of fingolimod in mice." Pharmacology research & perspectives vol. 3,3 (2015): e00135. doi: https://doi.org/10.1002/prp2.135
di Nuzzo L, Orlando R, Tognoli C, Di Pietro P, Bertini G, Miele J, Bucci D, Motolese M, Scaccianoce S, Caruso A, Mauro G, De Lucia C, Battaglia G, Bruno V, Fabene PF, Nicoletti F. Antidepressant activity of fingolimod in mice. Pharmacol Res Perspect. 2015 Jun;3(3):e00135. doi: 10.1002/prp2.135. Epub 2015 May 24. PMID: 26171219; PMCID: PMC4492751.
Copy Download .nbib Format: NLM
Nitric oxide-sensitive pulmonary hypertension in congenital rubella syndrome.

Case reports in critical care

Raimondi F, Migliaro F, Di Pietro E, Borgia F, Rapacciuolo A, Capasso L.
PMID: 25785205
Case Rep Crit Care. 2015;2015:198570. doi: 10.1155/2015/198570. Epub 2015 Feb 16.

Persistent pulmonary hypertension is a very rare presentation of congenital virus infection. We discuss the case of complete congenital rubella syndrome presenting at echocardiography with pulmonary hypertension that worsened after ductus ligation. Cardiac catheterization showed a normal pulmonary valve...

Cite
Raimondi F, Migliaro F, Di Pietro E, et al. Nitric oxide-sensitive pulmonary hypertension in congenital rubella syndrome. Case Rep Crit Care. 2015;2015:198570doi: 10.1155/2015/198570.
Raimondi, F., Migliaro, F., Di Pietro, E., Borgia, F., Rapacciuolo, A., & Capasso, L. (2015). Nitric oxide-sensitive pulmonary hypertension in congenital rubella syndrome. Case reports in critical care, 2015198570. https://doi.org/10.1155/2015/198570
Raimondi, Francesco, et al. "Nitric oxide-sensitive pulmonary hypertension in congenital rubella syndrome." Case reports in critical care vol. 2015 (2015): 198570. doi: https://doi.org/10.1155/2015/198570
Raimondi F, Migliaro F, Di Pietro E, Borgia F, Rapacciuolo A, Capasso L. Nitric oxide-sensitive pulmonary hypertension in congenital rubella syndrome. Case Rep Crit Care. 2015;2015:198570. doi: 10.1155/2015/198570. Epub 2015 Feb 16. PMID: 25785205; PMCID: PMC4345243.
Copy Download .nbib Format: NLM
Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An .

Oncology letters

Chiaravalloti A, Pagani M, Cantonetti M, DI Pietro B, Tavolozza M, Travascio L, DI Biagio D, Danieli R, Schillaci O.
PMID: 25621038
Oncol Lett. 2015 Feb;9(2):685-690. doi: 10.3892/ol.2014.2765. Epub 2014 Dec 03.

The aim of the present study was to investigate brain glucose metabolism in patients with Hodgkin disease (HD) after diagnosis and during chemotherapy treatment. Following the administration of first-line doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy, 74 HD patients...

Cite
Chiaravalloti A, Pagani M, Cantonetti M, et al. Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An . Oncol Lett. 2014;9(2):685-690doi: 10.3892/ol.2014.2765.
Chiaravalloti, A., Pagani, M., Cantonetti, M., DI Pietro, B., Tavolozza, M., Travascio, L., DI Biagio, D., Danieli, R., & Schillaci, O. (2015). Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An . Oncology letters, 9(2), 685-690. https://doi.org/10.3892/ol.2014.2765
Chiaravalloti, Agostino, et al. "Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An ." Oncology letters vol. 9,2 (2015): 685-690. doi: https://doi.org/10.3892/ol.2014.2765
Chiaravalloti A, Pagani M, Cantonetti M, DI Pietro B, Tavolozza M, Travascio L, DI Biagio D, Danieli R, Schillaci O. Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An . Oncol Lett. 2015 Feb;9(2):685-690. doi: 10.3892/ol.2014.2765. Epub 2014 Dec 03. PMID: 25621038; PMCID: PMC4301514.
Copy Download .nbib Format: NLM
Spin-polarised electrons in a one-magnet-only Mott spin junction.

Scientific reports

De Pietro L, Bertolini G, Peter Q, Cabrera H, Vindigni A, Gürlü O, Pescia D, Ramsperger U.
PMID: 29038570
Sci Rep. 2017 Oct 16;7(1):13237. doi: 10.1038/s41598-017-13453-6.

The current flowing through a Mott spin junction depends on the relative spin orientation of the two ferromagnetic layers comprising the "source" and "drain" sides of the junction. The resulting current asymmetry is detected as giant or tunnelling magnetoresistance...

Cite
De Pietro L, Bertolini G, Peter Q, et al. Spin-polarised electrons in a one-magnet-only Mott spin junction. Sci Rep. 2017;7(1):13237doi: 10.1038/s41598-017-13453-6.
De Pietro, L., Bertolini, G., Peter, Q., Cabrera, H., Vindigni, A., Gürlü, O., Pescia, D., & Ramsperger, U. (2017). Spin-polarised electrons in a one-magnet-only Mott spin junction. Scientific reports, 7(1), 13237. https://doi.org/10.1038/s41598-017-13453-6
De Pietro, L, et al. "Spin-polarised electrons in a one-magnet-only Mott spin junction." Scientific reports vol. 7,1 (2017): 13237. doi: https://doi.org/10.1038/s41598-017-13453-6
De Pietro L, Bertolini G, Peter Q, Cabrera H, Vindigni A, Gürlü O, Pescia D, Ramsperger U. Spin-polarised electrons in a one-magnet-only Mott spin junction. Sci Rep. 2017 Oct 16;7(1):13237. doi: 10.1038/s41598-017-13453-6. PMID: 29038570; PMCID: PMC5643535.
Copy Download .nbib Format: NLM
Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma.

Research and reports in urology

Bonetta A, Roviello G, Generali D, Zanotti L, Cappelletti MR, Pacifico C, Di Pierro F.
PMID: 28491861
Res Rep Urol. 2017 Apr 26;9:65-69. doi: 10.2147/RRU.S133538. eCollection 2017.

INTRODUCTION: Worldwide, bacterial resistance to antibiotic therapy is a major concern for the medical community. Antibiotic resistance mainly affects Gram-negative bacteria that are an important cause of lower urinary tract infections (LUTIs). Pelvic irradiation for prostate cancer is a...

Cite
Bonetta A, Roviello G, Generali D, et al. Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma. Res Rep Urol. 2017;9:65-69doi: 10.2147/RRU.S133538.
Bonetta, A., Roviello, G., Generali, D., Zanotti, L., Cappelletti, M. R., Pacifico, C., & Di Pierro, F. (2017). Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma. Research and reports in urology, 965-69. https://doi.org/10.2147/RRU.S133538
Bonetta, Alberto, et al. "Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma." Research and reports in urology vol. 9 (2017): 65-69. doi: https://doi.org/10.2147/RRU.S133538
Bonetta A, Roviello G, Generali D, Zanotti L, Cappelletti MR, Pacifico C, Di Pierro F. Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma. Res Rep Urol. 2017 Apr 26;9:65-69. doi: 10.2147/RRU.S133538. eCollection 2017. PMID: 28491861; PMCID: PMC5414750.
Copy Download .nbib Format: NLM
A 5-year retrospective study of demographic, anamnestic, and clinical factors related to psychiatric hospitalizations of adolescent patients.

Neuropsychiatric disease and treatment

Di Lorenzo R, Cimino N, Di Pietro E, Pollutri G, Neviani V, Ferri P.
PMID: 26848268
Neuropsychiatr Dis Treat. 2016 Jan 18;12:191-201. doi: 10.2147/NDT.S93874. eCollection 2016.

BACKGROUND: Psychiatric emergencies of children and adolescents have greatly increased during the last years, but this phenomenon has not been studied in detail. The aim of this study was to analyze the correlation between acute psychiatric hospitalizations of adolescents...

Cite
Di Lorenzo R, Cimino N, Di Pietro E, et al. A 5-year retrospective study of demographic, anamnestic, and clinical factors related to psychiatric hospitalizations of adolescent patients. Neuropsychiatr Dis Treat. 2016;12:191-201doi: 10.2147/NDT.S93874.
Di Lorenzo, R., Cimino, N., Di Pietro, E., Pollutri, G., Neviani, V., & Ferri, P. (2016). A 5-year retrospective study of demographic, anamnestic, and clinical factors related to psychiatric hospitalizations of adolescent patients. Neuropsychiatric disease and treatment, 12191-201. https://doi.org/10.2147/NDT.S93874
Di Lorenzo, Rosaria, et al. "A 5-year retrospective study of demographic, anamnestic, and clinical factors related to psychiatric hospitalizations of adolescent patients." Neuropsychiatric disease and treatment vol. 12 (2016): 191-201. doi: https://doi.org/10.2147/NDT.S93874
Di Lorenzo R, Cimino N, Di Pietro E, Pollutri G, Neviani V, Ferri P. A 5-year retrospective study of demographic, anamnestic, and clinical factors related to psychiatric hospitalizations of adolescent patients. Neuropsychiatr Dis Treat. 2016 Jan 18;12:191-201. doi: 10.2147/NDT.S93874. eCollection 2016. PMID: 26848268; PMCID: PMC4723031.
Copy Download .nbib Format: NLM
Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins.

Diabetes, metabolic syndrome and obesity : targets and therapy

Di Pierro F, Bellone I, Rapacioli G, Putignano P.
PMID: 25678808
Diabetes Metab Syndr Obes. 2015 Feb 04;8:89-96. doi: 10.2147/DMSO.S78877. eCollection 2015.

BACKGROUND: Statin intolerance is a medical condition often leading patients to nonadherence to the prescribed therapy or to a relevant reduction of the statin dosage. Both situations determine a totally or partially uncontrolled lipid profile, and these conditions unquestionably...

Cite
Di Pierro F, Bellone I, Rapacioli G, et al. Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins. Diabetes Metab Syndr Obes. 2015;8:89-96doi: 10.2147/DMSO.S78877.
Di Pierro, F., Bellone, I., Rapacioli, G., & Putignano, P. (2015). Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins. Diabetes, metabolic syndrome and obesity : targets and therapy, 889-96. https://doi.org/10.2147/DMSO.S78877
Di Pierro, Francesco, et al. "Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 8 (2015): 89-96. doi: https://doi.org/10.2147/DMSO.S78877
Di Pierro F, Bellone I, Rapacioli G, Putignano P. Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins. Diabetes Metab Syndr Obes. 2015 Feb 04;8:89-96. doi: 10.2147/DMSO.S78877. eCollection 2015. PMID: 25678808; PMCID: PMC4322873.
Copy Download .nbib Format: NLM
ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity.

Frontiers in pharmacology

Gauthier C, Ozvegy-Laczka C, Szakacs G, Sarkadi B, Di Pietro A.
PMID: 24312054
Front Pharmacol. 2013 Nov 07;4:138. doi: 10.3389/fphar.2013.00138. eCollection 2013.

ABCG2 is a key human ATP-binding cassette (ABC) transporter mediating cancer cell chemoresistance. In the case of ABCC1, another multidrug transporter, earlier findings documented that certain modulators greatly increase ABCC1-mediated glutathione (GSH) efflux and, upon depletion of intracellular GSH,...

Cite
Gauthier C, Ozvegy-Laczka C, Szakacs G, et al. ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity. Front Pharmacol. 2013;4:138doi: 10.3389/fphar.2013.00138.
Gauthier, C., Ozvegy-Laczka, C., Szakacs, G., Sarkadi, B., & Di Pietro, A. (2013). ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity. Frontiers in pharmacology, 4138. https://doi.org/10.3389/fphar.2013.00138
Gauthier, Charlotte, et al. "ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity." Frontiers in pharmacology vol. 4 (2013): 138. doi: https://doi.org/10.3389/fphar.2013.00138
Gauthier C, Ozvegy-Laczka C, Szakacs G, Sarkadi B, Di Pietro A. ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity. Front Pharmacol. 2013 Nov 07;4:138. doi: 10.3389/fphar.2013.00138. eCollection 2013. PMID: 24312054; PMCID: PMC3819521.
Copy Download .nbib Format: NLM
Infrared evidence of a Slater metal-insulator transition in NaOsO₃.

Scientific reports

Vecchio IL, Perucchi A, Di Pietro P, Limaj O, Schade U, Sun Y, Arai M, Yamaura K, Lupi S.
PMID: 24141899
Sci Rep. 2013 Oct 21;3:2990. doi: 10.1038/srep02990.

The magnetically driven metal-insulator transition (MIT) was predicted by Slater in the fifties. Here a long-range antiferromagnetic (AF) order can open up a gap at the Brillouin electronic band boundary regardless of the Coulomb repulsion magnitude. However, while many...

Cite
Vecchio IL, Perucchi A, Di Pietro P, et al. Infrared evidence of a Slater metal-insulator transition in NaOsO₃. Sci Rep. 2013;3:2990doi: 10.1038/srep02990.
Vecchio, I. L., Perucchi, A., Di Pietro, P., Limaj, O., Schade, U., Sun, Y., Arai, M., Yamaura, K., & Lupi, S. (2013). Infrared evidence of a Slater metal-insulator transition in NaOsO₃. Scientific reports, 32990. https://doi.org/10.1038/srep02990
Vecchio, I Lo, et al. "Infrared evidence of a Slater metal-insulator transition in NaOsO₃." Scientific reports vol. 3 (2013): 2990. doi: https://doi.org/10.1038/srep02990
Vecchio IL, Perucchi A, Di Pietro P, Limaj O, Schade U, Sun Y, Arai M, Yamaura K, Lupi S. Infrared evidence of a Slater metal-insulator transition in NaOsO₃. Sci Rep. 2013 Oct 21;3:2990. doi: 10.1038/srep02990. PMID: 24141899; PMCID: PMC3801134.
Copy Download .nbib Format: NLM
High Conductivity in Molecularly p-Doped Diketopyrrolopyrrole-Based Polymer: The Impact of a High Dopant Strength and Good Structural Order.

Advanced materials (Deerfield Beach, Fla.)

Karpov Y, Erdmann T, Raguzin I, Al-Hussein M, Binner M, Lappan U, Stamm M, Gerasimov KL, Beryozkina T, Bakulev V, Anokhin DV, Ivanov DA, Günther F, Gemming S, Seifert G, Voit B, Di Pietro R, Kiriy A.
PMID: 27172371
Adv Mater. 2016 Jul;28(28):6003-10. doi: 10.1002/adma.201506295. Epub 2016 May 12.

[3]-Radialene-based dopant CN6-CP studied herein, with its reduction potential of +0.8 versus Fc/Fc+ and the lowest unoccupied molecular orbital level of -5.87 eV, is the strongest molecular p-dopant reported in the open literature, so far. The efficient p-doping of...

Cite
Karpov Y, Erdmann T, Raguzin I, et al. High Conductivity in Molecularly p-Doped Diketopyrrolopyrrole-Based Polymer: The Impact of a High Dopant Strength and Good Structural Order. Adv Mater. 2016;28(28):6003-10doi: 10.1002/adma.201506295.
Karpov, Y., Erdmann, T., Raguzin, I., Al-Hussein, M., Binner, M., Lappan, U., Stamm, M., Gerasimov, K. L., Beryozkina, T., Bakulev, V., Anokhin, D. V., Ivanov, D. A., Günther, F., Gemming, S., Seifert, G., Voit, B., Di Pietro, R., & Kiriy, A. (2016). High Conductivity in Molecularly p-Doped Diketopyrrolopyrrole-Based Polymer: The Impact of a High Dopant Strength and Good Structural Order. Advanced materials (Deerfield Beach, Fla.), 28(28), 6003-10. https://doi.org/10.1002/adma.201506295
Karpov, Yevhen, et al. "High Conductivity in Molecularly p-Doped Diketopyrrolopyrrole-Based Polymer: The Impact of a High Dopant Strength and Good Structural Order." Advanced materials (Deerfield Beach, Fla.) vol. 28,28 (2016): 6003-10. doi: https://doi.org/10.1002/adma.201506295
Karpov Y, Erdmann T, Raguzin I, Al-Hussein M, Binner M, Lappan U, Stamm M, Gerasimov KL, Beryozkina T, Bakulev V, Anokhin DV, Ivanov DA, Günther F, Gemming S, Seifert G, Voit B, Di Pietro R, Kiriy A. High Conductivity in Molecularly p-Doped Diketopyrrolopyrrole-Based Polymer: The Impact of a High Dopant Strength and Good Structural Order. Adv Mater. 2016 Jul;28(28):6003-10. doi: 10.1002/adma.201506295. Epub 2016 May 12. PMID: 27172371.
Copy Download .nbib Format: NLM
A calorimetric assay for dicyclomine hydrochloride using bromocresol green.

Journal of pharmaceutical and biomedical analysis

Raggi MA, Cavrini V, Di Pietra AM.
PMID: 16867689
J Pharm Biomed Anal. 1985;3(3):287-91. doi: 10.1016/0731-7085(85)80034-0.

No abstract available.

Cite
Raggi MA, Cavrini V, Di Pietra AM. A calorimetric assay for dicyclomine hydrochloride using bromocresol green. J Pharm Biomed Anal. 1985;3(3):287-91doi: 10.1016/0731-7085(85)80034-0.
Raggi, M. A., Cavrini, V., & Di Pietra, A. M. (1985). A calorimetric assay for dicyclomine hydrochloride using bromocresol green. Journal of pharmaceutical and biomedical analysis, 3(3), 287-91. https://doi.org/10.1016/0731-7085(85)80034-0
Raggi, M A, et al. "A calorimetric assay for dicyclomine hydrochloride using bromocresol green." Journal of pharmaceutical and biomedical analysis vol. 3,3 (1985): 287-91. doi: https://doi.org/10.1016/0731-7085(85)80034-0
Raggi MA, Cavrini V, Di Pietra AM. A calorimetric assay for dicyclomine hydrochloride using bromocresol green. J Pharm Biomed Anal. 1985;3(3):287-91. doi: 10.1016/0731-7085(85)80034-0. PMID: 16867689.
Copy Download .nbib Format: NLM
Periprosthetic bone density as outcome of therapeutic response.

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

Iolascon G, Di Pietro G, Capaldo A, Gioia C, Gatto S, Gimigliano F.
PMID: 22461288
Clin Cases Miner Bone Metab. 2010 Jan;7(1):27-31.

The bone surrounding a prosthetic implant normally experiences a progressive quantitative reduction as a result of stress shielding and wear debris production, that can lead to the aseptic loosening of the implant. Dual-energy X-ray absorptiometry (DXA), using software algorithms,...

Cite
Iolascon G, Di Pietro G, Capaldo A, et al. Periprosthetic bone density as outcome of therapeutic response. Clin Cases Miner Bone Metab. 2010;7(1):27-31
Iolascon, G., Di Pietro, G., Capaldo, A., Gioia, C., Gatto, S., & Gimigliano, F. (2010). Periprosthetic bone density as outcome of therapeutic response. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 7(1), 27-31.
Iolascon, Giovanni, et al. "Periprosthetic bone density as outcome of therapeutic response." Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases vol. 7,1 (2010): 27-31.
Iolascon G, Di Pietro G, Capaldo A, Gioia C, Gatto S, Gimigliano F. Periprosthetic bone density as outcome of therapeutic response. Clin Cases Miner Bone Metab. 2010 Jan;7(1):27-31. PMID: 22461288; PMCID: PMC2898003.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 518 entries